Laux, Porter, Cavanaugh (212) 829-5484

Today's Healthcare Stories
News and Views | Earnings | Sector News, M&A, Capital Raises | Research Away

News and Views

 

Biotech/Pharma:  PRX OREX GNVC NABI HSP SNTA AMGN SQNM JAZZ

Healthcare Services: OCR MD CVH OMI

Restaurants/Publishing/Retail: LOCM BKC DPZ

HMO +7% best performing group of the week..hospital stocks were strong on Washington headlines about an extension of funding to state Medicaid plans.

Earnings

 

ISIS Isis Pharmaceuticals reports Q2 EPS (25c) vs. consensus of (15c) - Reports Q2 revenue $23.5M vs. consensus of $25.63M. lowered its FY10

operating loss guidance by approximately 10%-20% to a pro forma net operating loss in the mid to high $40M range

OSTE Osteotech reports Q2 EPS 1c vs. consensus of (2c) - Reports Q2 revenue $24M vs. consensus of $24.18M.

WCG WellCare Health Slips To Loss In Q2, Lifts Lower End Of FY10 EPS View

AMED Amedisys Guides FY EPS 4.20-4.50 vs 4.71. Revs lower..repurchase $60M of common stock

CYPB Cypress Bioscience reports Q2 EPS ($0.05) vs Reuters ($0.11). Company reports revenues of $9.1M vs Reuters $8.9M.

SSP E.W. Scripps reports Q3 EPS 3c vs. consensus of 1c - Reports Q3 revenue $188.79M vs. consensus of $179.9M.

KG King Pharma .17c vs .16c. Revs $370.9M vs $361.2M

Sector News, M&A, Capital Raises

 

RPRX Repros Therapeutics Inc. said Monday it obtained positive written feedback from the Division of Reproductive and Urologic Products

regarding its drug candidate Androxal.

RAD Rite Aid To Amend Its $1.175 Bln Existing Revolving Credit Facility Due 2012 With New $1.175 Bln Facility Due 2015

MDTH Medcath to sell Arizona Heart Hospital to Vanguard health systems for $31.5M

XOMA XOMA Limited expects to sell 24.9M shares for $6.8M to Azimuth

CLDA Clinical Data says PDUFA date for Vilazodone is January 22, 2011

Research Away

 

ZGEN Zymogenetics initiated with a Buy at Canaccord - Target $7.

SKH Skilled Healthcare Group upgraded to buy from hold at Jefferies

MYL Mylan upgraded to outperform from market perform at Bernstein

 

AFTER CLOSE

After Market Close		Actual	Reuters*	Actual	Reuters*
		ACAD	Acadia Pharmaceuticals		(0.17)		1.8M
		ALC	Assisted Living Concepts		0.39		58.6M
		ANIK	Anika Therapeutics		n/a		n/a
		ARRY	Array Biopharma		(0.32)		16.1M
		ATHX	Athersys, Inc.		(0.16)		1.6M
		AVII	AVI BioPharma		(0.05)		2.9M
		BJGP	BMP Sunstone		0.01		34.9M
		CCO	Clear Channel Outdoor		0.02		709.8M
		ERES	eResearchTech		0.02		25.4M
		ESC	Emeritus Corp		(0.28)		236.6M
		MDTH	Medcath		0.05		133.9M
		MDVN	Medivation		(0.36)		16.4M
		MRGE	Merge Healthcare		(0.07)		35.5M
		PARD	Poniard Pharmaceuticals		(0.20)		0.0M
		PEGA	Pegasystems		0.17		85.6M
		PRXL	Parexel		0.30		297.8M
		SCLN	SciClone Pharmaceuticals		0.08		19.7M
		SLXP	Salix Pharmaceuticals		0.10		93.6M
		SNTA	Synta Pharmaceuticals		(0.22)		4.2M
		TAST	Carrols Restaurant		0.22		204.2M
		TSPT	Transcept Pharmaceuticals		(0.15)		3.1M
		UGNE	Unigene Laboratories		n/a		n/a
		VCGH	VCG Holding		0.05		14.1M	n/a
		XOMA	XOMA Limited		(0.07)		6.6M

Disclaimer: Prepared by staff of Cantor Fitzgerald & Co. ("Cantor") and is for information purposes only. It is not intended to form the basis of any investment decision, should not be considered a recommendation by Cantor or any other person and does not constitute an offer or solicitation with respect to the purchase or sale of any investment nor is it a confirmation of terms. Any calculations and valuations presented herein are intended as a basis for discussion. Sources of information are believed to be reliable but Cantor makes no representation and gives no warranty that the information contained herein is accurate or complete. Any opinions or estimates given may change. Cantor undertakes no obligation to provide recipients with any additional information or any update to or correction of the information contained herein. This material is intended solely for institutional investors and investors who Cantor reasonably believes are institutional investors. Cantor, its officers, employees, affiliates and partners shall not be liable to any person in any way whatsoever for any losses, costs or claims howsoever arising from any inaccuracies or omissions in the information contained herein or any reliance on that information. Cantor may have positions in financial instruments mentioned, may have acquired such positions at prices no longer available, and may have interests different or adverse to your interests. No liability is accepted by Cantor for any loss that may arise from any use of the information contained herein or derived here from. This product may not be reproduced or redistributed outside the recipient's organization. Sources: Cantor Fitzgerald & Co., Reuters, Bloomberg, CNBC, Dow Jones, Marketwatch, Trade-Alert, and the Wall Street Journal. ***All eco data from Bloomberg and DJ